Is the Stock Market Headed for an AI-Bubble Burst? Here Are 2 Industrial Stocks That Can Offset Tech Stock Volatility.

3M: shares are up ~96% since Feb 2024 as the company returned to revenue growth in 2025 (+1.5% to $24.9B) and expanded adjusted operating margin by 200 bps to 23.4%; full-year EPS fell 10% but Q4 adjusted EPS rose 9%, suggesting restructuring/recovery nearing completion heading into 2026. Cameco: produced ~15% of global uranium in 2025, reported 2025 revenue of $3.48B (+11% YoY) and adjusted EPS +114% YoY, with very low production cost (~CA$20/lb ≈ $15/US) vs spot uranium ≈ $85/lb, net margin ~16.9% and D/E of 0.14; signed a $1.9B supply deal with India for 22M lbs (2027–2035). The piece frames both names as defensive hedges against a potential AI-driven market bubble rather than catalysts that would move broad markets.

Analysis

Winners extend beyond the two names called out: a sustained bid for uranium structurally re-rates front‑end specialists (miners, fabricators, enrichment services) and capital‑light SMR/engineering vendors, while pressure on AI darlings would transfer real capital into cash generative industrials and defensive cyclicals. For 3M, the key re‑rating mechanism is margin normalization plus removal of headline legal risk — if that happens, multiples can re‑expand even with mid‑single‑digit topline growth because free cash flow will become scarce capital’s refuge. Cameco’s optionality is asymmetric: its high‑grade cost curve gives convexity to higher spot/term prices, but utility contracting cadence and secondary supply (inventory drawdowns, downblends, Kazakh policy shifts) can create multi‑quarter volatility even as the long‑term demand case strengthens.

Tail risks differ in timing and size: 3M is most sensitive to litigation shocks and capex/working capital surprises over quarters; a single adverse ruling or reserve increase can erase a year of positive operating leverage. Cameco’s tail risks are geopolitical and structural — rapid restart of Kazakh output or a sudden release of secondary inventories could send spot prices lower within months, reversing sentiment despite multi‑year demand drivers. Conversely, regulatory/financing milestones for new reactors and multi‑year term contracting are 12–48 month catalysts that would re‑rate producers.

Trade construction should prioritize convexity and optionality rather than outright buy-and-hold given the asymmetric risks. Use concentrated, time‑boxed option exposure on Cameco to capture multi‑year secular upside while limiting downside, and tilt 3M exposure toward income/overlay strategies (dividends, covered calls) to harvest carry while waiting for litigation clarity. Hedge AI‑concentration risk with cheap put spreads on the largest momentum names rather than broad index shorts — that limits carry and captures a ‘bubble pop’ shock if it happens.

Contrarian read: the market is simultaneously too enthusiastic about uranium’s uninterrupted ascent and too sanguine about legacy liabilities at industrials. That makes straight equity ownership suboptimal — prefer structured exposure that benefits from nuclear upside while protecting against inventory cycles and litigation shocks at established industrials.

Key Decisions for Investors

• Long CCJ via long‑dated calls: buy CCJ Jan‑2028 LEAP 2:1 ratio (2 long calls funded by 1 short shorter‑dated call) sized 2–4% NAV. Rationale: captures multi‑year term contracting/upside in uranium with max loss = premium (~100% of premium), target 50–100% return if term/spot prices re‑accelerate within 12–30 months.
• Defensive core on MMM with income overlay: buy MMM stock sized 3–5% NAV and sell 1–2X 6–9 month covered calls at ~10% OTM to collect yield. Rationale: generates 6–12% near‑term carry and limits downside; downside risk if litigation reserve spikes — stress loss scenario ~25–35%.
• Hedge AI‑concentration shock: buy NVDA Jul‑2026 1–1.5% NAV put spreads (e.g., 25–15 delta puts, 2:1 spread width) as a tactical tail hedge. Rationale: low carry; pays off if momentum/AI names correct sharply within 3–9 months; expected payback >3x on >20% drawdown in NVDA.
• Event watch pair: if uranium spot falls >20% or Kazakh guidance materially increases, switch CCJ exposure from calls to 6–12 month put protection or trim to zero. Conversely, add to CCJ calls on confirmed multi‑quarter utility contracting headlines or final investment decisions for >1 GW reactors (monitor 12–36 month pipeline).
• Size & risk rules: cap aggregate exposure to nuclear + industrial idiosyncratic trades at 10% NAV and single‑name option premiums at 3–4% NAV to avoid concentration into a single sector/catalyst; set automatic rebalancing triggers at ±30% P&L on individual positions.